Prolight Diagnostics AB (NGM:PRLD) Cyclically Adjusted FCF per Share: kr-19.04 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:PRLD Prolight Diagnostics AB NGM:PRLD
30 GF Score
Price kr20.80
! 2 Warning Signs
View Full Analysis

What is Prolight Diagnostics AB Cyclically Adjusted FCF per Share?

Prolight Diagnostics AB NGM:PRLD -5.24% 30 Cyclically Adjusted FCF per Share is kr-19.04 as of Jun. 2026. GuruFocus rates NGM:PRLD with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Prolight Diagnostics AB's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr-0.047. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-19.04 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-18), Prolight Diagnostics AB's current stock price is kr20.80. Prolight Diagnostics AB's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr-19.04. Prolight Diagnostics AB's Cyclically Adjusted Price-to-FCF of today is .


Prolight Diagnostics AB  (NGM:PRLD) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Prolight Diagnostics AB Cyclically Adjusted FCF per Share Related Terms


Prolight Diagnostics AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Prolight Diagnostics AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prolight Diagnostics AB Cyclically Adjusted FCF per Share Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -18.80

Prolight Diagnostics AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -18.80 -18.94 -19.04

NGM:PRLD vs ISRG, BDX, RMD: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's Cyclically Adjusted Price-to-FCF falls into.


NGM:PRLD
30GF Score
Prolight Diagnostics AB NGM:PRLD
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prolight Diagnostics AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Prolight Diagnostics AB's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.047/134.6100*134.6100
=-0.047

Current CPI (Jun. 2026) = 134.6100.

Prolight Diagnostics AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.183 101.138 -0.244
201612 0.000 102.022 0.000
201703 -13.678 102.022 -18.047
201706 -6.538 102.752 -8.565
201709 -1.411 103.279 -1.839
201712 -5.791 103.793 -7.510
201803 -11.200 103.962 -14.502
201806 -6.764 104.875 -8.682
201809 -12.952 105.679 -16.498
201812 -8.972 105.912 -11.403
201903 -6.118 105.886 -7.778
201906 -6.103 106.742 -7.696
201909 -6.537 107.214 -8.207
201912 -6.088 107.766 -7.604
202003 -4.805 106.563 -6.070
202006 -3.344 107.498 -4.187
202009 0.863 107.635 1.079
202012 -5.206 108.296 -6.471
202103 -0.767 108.360 -0.953
202106 -1.015 108.928 -1.254
202109 -1.721 110.338 -2.100
202112 -0.942 112.486 -1.127
202203 0.792 114.825 0.928
202206 -5.667 118.384 -6.444
202209 -4.316 122.296 -4.751
202212 0.000 126.365 0.000
202303 -3.357 127.042 -3.557
202306 -4.274 129.407 -4.446
202309 -4.643 130.224 -4.799
202312 -1.109 131.912 -1.132
202403 -2.379 132.205 -2.422
202406 -1.600 132.716 -1.623
202409 -3.209 132.304 -3.265
202412 -1.719 132.987 -1.740
202503 -1.722 132.825 -1.745
202506 -0.754 133.699 -0.759
202509 -1.763 133.480 -1.778
202512 -1.656 133.380 -1.671
202603 -1.946 133.550 -1.961
202606 -0.047 134.610 -0.047

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-19.04 mean?
Prolight Diagnostics AB (NGM:PRLD) has a Cyclically Adjusted FCF per Share of kr-19.04 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Prolight Diagnostics AB and its competitors.
Is Prolight Diagnostics AB's Cyclically Adjusted FCF per Share too high?
Prolight Diagnostics AB's current Cyclically Adjusted FCF per Share is kr-19.04. Overall, Prolight Diagnostics AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Prolight Diagnostics AB's Cyclically Adjusted FCF per Share of kr-19.04 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Prolight Diagnostics AB and its competitors. Prolight Diagnostics AB's current Cyclically Adjusted FCF per Share is kr-19.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (NGM:PRLD) has a current Cyclically Adjusted FCF per Share of kr-19.04. The current Cyclically Adjusted FCF per Share is kr-19.04. Prolight Diagnostics AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Prolight Diagnostics AB (NGM:PRLD), the current Cyclically Adjusted FCF per Share is kr-19.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prolight Diagnostics AB Business Description

Address Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
30GF Score

Get the complete analysis for NGM:PRLD

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.80
Price